Investing in Innovation - Parkwalk Advisors

180+

The UK’s most active investor in UK university spin-outs

£500M

Over £500m raised; invested into over 180 companies

£145M

Cash returned to investors via exits

£1.2Bn

Part of FTSE 250 sector specialist group with £1.2bn net assets

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

Performance

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Learn More

Meet the Parkwalk team

Combining our diverse range of skills and experience with integrity and transparency the Parkwalk team has an outstanding track record for supporting high-growth innovation that delivers returns.

Empowering Innovation

Parkwalk Funds invest in dynamic university spin-out companies seeking to commercialise intellectual property and technology. From investing in seed to later stage companies, we help fantastic management teams develop and build world-class successful businesses.

Oxford Brain Diagnostics

Oxford Brain Diagnostics is the result of an 8-year collaboration between Professor Steven Chance (neuroscience and pathology) and Professor Mark Jenkinson (brain imaging), and has resulted in the development of the Cortical Disarray Measurement (CDM), a novel approach that uses MRI scans to provide an index of the health of the cellular circuits in patients’

xWatts Ltd

xWatts, a University of Cambridge spin-out, is developing an intelligent energy management software that reduces costs and emissions by 30% in large commercial buildings via autonomation and predictive control. With minimal user intervention, the company’s software automates and controls all isolated processes, such as operations, heating, cooling or storage.

Psyomics

Psyomics has utilised its experience from University labs and the Delta clinical trial to create a digital mental health assessment tool called Censeo. Censeo delivers a psychiatrist quality mental health assessment to help reduce misdiagnosis and get patients on the correct treatment pathway quicker, whilst improving GP and psychiatry efficiency.

View Portfolio

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
ASP.NET_SessionID	session	This cookie is used by the Investor Portal platform to identify the users’ session on the server. It will live as long as the browser remains open – once the browser is closed the cookie is deleted by the browser.
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.

Functional

Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

Cookie	Duration	Description
__cf_bm	30 minutes	This cookie, set by Cloudflare, is used to support Cloudflare Bot Management.
aka_debug	session	Vimeo sets this cookie which is essential for the website to play video functionality.

Performance

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Cookie	Duration	Description
_gat	1 minute	This cookie is installed by Google Universal Analytics to restrain request rate and thus limit the collection of data on high traffic sites.

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
vuid	2 years	Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.

About Parkwalk

Parkwalk is one of the UK’s leading growth fund managers backing world-changing technologies emerging out of UK universities and research institutions with the aim of delivering world-class returns.

We back high potential, hard science technology companies that aim to shape the future by commercialising innovation in sectors of strategic importance to UK Plc, such as AI, big data, life science, materials, cleantech, future of mobility, medtech and quantum computing.

Meet the Parkwalk team

Empowering Innovation

Ian Broadhurst

Consultant at Parkwalk Advisors

Ian Broadhurst

Consultant at Parkwalk Advisors

Greater Guildford Area, United Kingdom

Overview

Work Experience

Parkwalk Advisors

Consultant

2011 - Current

Relevant Websites